KD Market Insights projects growth in Japan's polyimide electrostatic chuck and Fragile X syndrome treatment markets

KD Market Insights released two separate market forecasts for Japan. The polyimide electrostatic chuck market, essential for semiconductor wafer handling, is projected to reach US$2.42 billion by 2035, expanding at a 7.5 % CAGR from a 2024 size of US$1.2 billion. Surveyed industry executives linked the growth to expanding AI and high‑performance computing chip production, power‑semiconductor demand, and increased automation in wafer handling. Major suppliers cited include Shinko Electric Industries, Kyocera, and NGK.

In the healthcare sector, the Japanese Fragile X syndrome treatment market is expected to grow to US$3.99 million by 2035, with a 7.51 % CAGR from US$1.67 million in 2024. Respondents highlighted rising investment in rare‑disease research, greater awareness of the condition, and the shift toward precision‑medicine and gene‑therapy approaches. Companies such as Aelis Farma, Roche, and Ovid Therapeutics are active, while the market faces a lack of curative therapies.

Both reports underscore Japan’s broader trend of heightened R&D spending and the role of specialized equipment and therapeutics in future economic growth.